rAAVen Therapeutics
PrivateLast Round
Accelerator
Oct 5, 2022
Momentum
Top 10%
of companies Caplight tracks
Company Overview
rAAVen Therapeutics operates in Healthcare & Life Sciences and is based in Lund. Its latest recorded funding round was an Accelerator round in October 2022.
rAAVen Therapeutics is a biotechnology company that develops next-generation adeno-associated virus (AAV) vectors for precision gene therapy delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
rAAVen Therapeutics Comparables
Compare rAAVen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsigen | 84% | |
| Byongen Therapeutics | 82% | |
| Apertura Gene Therapy | 81% |
For institutional investors. Book with your work email.
rAAVen Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
rAAVen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SmiLe Venture Hub | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 110% MoM, reaching 1.1K.
- Mar 2, 2026
Monthly visitors increased 251% MoM.
For institutional investors. Book with your work email.
rAAVen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about rAAVen Therapeutics's valuation, stock price, and market status.
Is rAAVen Therapeutics a public or private company?
rAAVen Therapeutics is a private company.
What is the current stock price of rAAVen Therapeutics?
rAAVen Therapeutics is a private company, so its shares have no public market price. Caplight tracks rAAVen Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is rAAVen Therapeutics worth (valuation)?
Valuation information for rAAVen Therapeutics is not publicly available.
Can I buy rAAVen Therapeutics stock?
rAAVen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was rAAVen Therapeutics's last funding round?
rAAVen Therapeutics's most recent funding round was Accelerator on October 5, 2022.
Who are the main investors in rAAVen Therapeutics?
Key investors in rAAVen Therapeutics include SmiLe Venture Hub.
Will rAAVen Therapeutics IPO soon?
No public IPO plans have been announced for rAAVen Therapeutics.
How can I track rAAVen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in rAAVen Therapeutics's shares on secondary markets.